Prince of Wales Hospital, Chinese University of Hong Kong
Hong Kong
NCT Number: NCT05762198
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or transurethral resection of prostate (TURP) arm.
Looking for future studies?
Notify Me50 year–80 year
Male
Interventional
Not applicable
Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the REZUM arm, water vapour treatment is performed for all subjects under local anaesthesia.
In the TURP arm, all men will receive TURP operation under general or spinal anaesthesia
Time frame: Baseline, 3 months, 6 months and 12 months after intervention
IPSS score ranging from 0-35 (the higher the worse)
Time frame: At 3 months
Percentage of patients successfully TWOC
Time frame: 30 days after intervention
Assessed by Clavien-Dindo classification
Time frame: Baseline, 3 months, 6 months and 12 months after intervention
Change in quality of life assessed by change in International Prostate QOL score (ranges from 0 to 6, the higher the worse)
Time frame: Baseline, 3 months, 6 months and 12 months after intervention
It is assessed by maximum flow rate and post void volume in uroflowmetry
Time frame: Baseline, 3 months, 6 months and 12 months after intervention
Score 1-5 (the lower the worse)
Time frame: On Discharge
Measure the hours of in-patient hospitalisation
Time frame: 30 days after intervention
Percentage of patients with unplanned readmission
Chinese University of Hong Kong
Other
A Randomized Controlled Trial Comparing Water Vapour Thermal Therapy (Rezūm) and TURP in Men With Benign Prostatic Hyperplasia in Refractory Urinary Retention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06051162
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Seoul, South Korea
View Trial DetailsNCT07806539
Genital Diseases, Genital Diseases, Male
Antalya, Turkey (Türkiye)
View Trial DetailsNCT06837896
Genital Diseases, Genital Diseases, Male
Jinan, Shandong, China
View Trial DetailsNCT05864144
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial Details